PDS Biotechnology (PDSB) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free PDSB Stock Alerts $3.25 +0.05 (+1.56%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancerglobenewswire.com - April 23 at 8:00 AMPDS Biotechnology Corporation (PDSB)finance.yahoo.com - April 20 at 1:10 PMPDS Biotechnology (NASDAQ:PDSB) Trading Down 8.8%marketbeat.com - April 20 at 12:41 AMPDS Biotechnology Corp (PDSB)investing.com - April 5 at 1:56 PMLuminous quasar PDS 456 explored with MUSEmsn.com - April 3 at 4:18 PMPDS Biotechnology Corporation's (NASDAQ:PDSB) market cap dropped US$1.5m last week; individual investors who hold 59% were hit as were institutionsfinance.yahoo.com - March 30 at 3:51 PMTwitch online gamer Ninja says he has form of skin cancer in 'early stages'ca.style.yahoo.com - March 29 at 5:02 PMPDS Biotechnology Co. (NASDAQ:PDSB) to Post Q1 2024 Earnings of ($0.40) Per Share, B. Riley Forecastsmarketbeat.com - March 29 at 8:16 AMPDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 28 at 1:32 PMPDS Biotechnology (NASDAQ:PDSB) Stock Rating Reaffirmed by B. Rileymarketbeat.com - March 28 at 12:33 PMResearch Analysts Offer Predictions for PDS Biotechnology Co.'s FY2028 Earnings (NASDAQ:PDSB)marketbeat.com - March 28 at 8:59 AMQ4 2023 PDS Biotechnology Corp Earnings Callfinance.yahoo.com - March 28 at 3:31 AMPDS Biotechnology Corp (PDSB) Reports Full Year 2023 Financial Results and Clinical Strategy Updatefinance.yahoo.com - March 27 at 12:30 PMPDSB Stock Earnings: PDS Biotechnology Beats EPS for Q4 2023investorplace.com - March 27 at 12:05 PMHC Wainwright Reiterates "Buy" Rating for PDS Biotechnology (NASDAQ:PDSB)marketbeat.com - March 27 at 11:00 AMPDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Resultsglobenewswire.com - March 27 at 7:30 AMPDS Biotechnology FY 2023 Earnings Previewmsn.com - March 27 at 12:53 AMPDS Biotechnology (PDSB) Scheduled to Post Quarterly Earnings on Wednesdaymarketbeat.com - March 21 at 11:26 AMPDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Resultsglobenewswire.com - March 20 at 8:00 AMMP: Authorities Grappling With Suspicious PDS Wheat Black Marketingmsn.com - March 18 at 5:23 PMMP: Police Seize 30 Sacks Of PDS Rice Out For Black Marketingmsn.com - March 17 at 9:33 AMGFA, PDS Ventures to invest $200,000 in new fashion innovatorsmsn.com - March 14 at 8:24 PMThe 3 Most Undervalued Biotech Stocks to Buy in March 2024investorplace.com - March 13 at 10:55 AMPDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®globenewswire.com - March 13 at 8:00 AMPDS Biotechnology (NASDAQ:PDSB) Raised to "Hold" at StockNews.commarketbeat.com - March 8 at 11:24 PMPDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Dataseekingalpha.com - January 26 at 7:39 PMPDS Biotech names Kirk V. Shepard as Chief Medical Officermsn.com - January 23 at 8:50 AMPDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conferencefinance.yahoo.com - January 16 at 12:48 PMPDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conferencefinance.yahoo.com - January 16 at 12:48 PMAll You Need to Know About PDS Biotechnology (PDSB) Rating Upgrade to Buyfinance.yahoo.com - January 2 at 3:02 PMResearch Analysts Set Expectations for PDS Biotechnology Co.'s FY2023 Earnings (NASDAQ:PDSB)marketbeat.com - December 21 at 7:46 AMPDS Biotechnology (NASDAQ:PDSB) Given "Overweight" Rating at Cantor Fitzgeraldmarketbeat.com - December 21 at 7:36 AMPDSB Jan 2024 7.500 callca.finance.yahoo.com - December 17 at 12:26 AMPDSB Feb 2024 7.500 callca.finance.yahoo.com - December 16 at 7:26 PMPDSB Jan 2024 7.500 putca.finance.yahoo.com - December 16 at 7:26 PMPDS Biotechnology Stock (NASDAQ:PDSB) Dividends: History, Yield and Datesbenzinga.com - December 8 at 5:38 PMPDS Biotechnology CFO Matthew Hill to Exit; Lars Boesgaard Named as Replacementmarketwatch.com - November 28 at 8:31 AMPDS Biotechnology Appoints Lars Boesgaard To Succeed Matthew Hill As CFOmarkets.businessinsider.com - November 28 at 8:31 AMPDS Biotech Appoints Lars Boesgaard as Chief Financial Officerfinance.yahoo.com - November 28 at 8:31 AMPositive Outlook for PDS Biotechnology: Strong Q3 Financials, Promising Development Pipeline, and Strategic Advancementsmarkets.businessinsider.com - November 17 at 7:32 AMPDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 15 at 5:53 PMPDS Biotechnology Shares Rise 20% After Narrower-Than-Expected 3Q Lossmarketwatch.com - November 14 at 9:28 PMPDS Biotechnology Corporation: PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 14 at 4:28 PMPDS Biotechnology Corp (PDSB) Reports Increased Net Loss in Q3 2023 Amid Advancements in ...finance.yahoo.com - November 14 at 4:28 PMPDS Biotechnology: Q3 Earnings Insightsbenzinga.com - November 14 at 8:55 AMPDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 14 at 8:55 AMA Preview Of PDS Biotechnology's Earningsbenzinga.com - November 13 at 2:45 PMAnalysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Shattuck Labs (STTK)markets.businessinsider.com - November 10 at 2:32 AMPDS Biotech reports encouraging survival data for HPV 16+ cancer therapymsn.com - November 9 at 4:27 PMPDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of PDS0101-Based Triple Combination Therapy in Advanced HPV16-Positive Cancer Patients which Show 75% Survival of ICI Naïve Patients at 36 Monthsfinance.yahoo.com - November 9 at 9:38 AM Get PDS Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PDSB and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… PDSB Media Mentions By Week PDSB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PDSB News Sentiment▼0.030.44▲Average Medical News Sentiment PDSB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PDSB Articles This Week▼32▲PDSB Articles Average Week Get PDS Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PDSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EBS News Today IOBT News Today RNAC News Today ANIX News Today CLRB News Today BRNS News Today ORMP News Today INCR News Today MCRB News Today ANVS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PDSB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
